Trials / Completed
CompletedNCT00850889
Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Allergan Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Comparison of the safety and effectiveness of Juvederm Ultra with lidocaine compared with Restylane in the correction of nasolabial folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine | Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL |
| DEVICE | A gel of hyaluronic acid (concentration of 20 mg/mL) | Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2009-02-25
- Last updated
- 2019-01-09
- Results posted
- 2011-04-21
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00850889. Inclusion in this directory is not an endorsement.